PE68199A1 - PHARMACEUTICAL COMPOSITION OF GASTRIC RESIDENCE - Google Patents
PHARMACEUTICAL COMPOSITION OF GASTRIC RESIDENCEInfo
- Publication number
- PE68199A1 PE68199A1 PE1998000281A PE00028198A PE68199A1 PE 68199 A1 PE68199 A1 PE 68199A1 PE 1998000281 A PE1998000281 A PE 1998000281A PE 00028198 A PE00028198 A PE 00028198A PE 68199 A1 PE68199 A1 PE 68199A1
- Authority
- PE
- Peru
- Prior art keywords
- acid
- pharmaceutical composition
- salts
- gastric residence
- generating system
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
Abstract
CARACTERIZADA PORQUE COMPRENDE a)UN PRINCIPIO ACTIVO QUE CONSISTE DE UNA BENZAMIDA O SU SAL, PARTICULARMENTE ES EL CLORHIDRATO DE TIAPRIDE, AMISULPRIDA, SULPIRIDA, O SUS SALES, O SUS ENANTIOMEROS; b)UN SISTEMA GENERADOR DE CO2, COMPRENDE AL MENOS UN AGENTE GENERADOR DE CO2 Y AL MENOS UN COMPUESTO ACIDO ELEGIDO ENTRE ACIDO MONO Y POLICARBOXILICOS; DE PREFERENCIA ES EL ACIDO TARTARICO, SUCCINICO, CITRICO O SUS SALES; c)UN MEDIO QUE PERMITE LA RETENCION PARCIAL DE CO2 GENERADO POR DICHO SISTEMA GENERADOR DE CO2, QUE CONSISTE AL MENOS DE UN POLIMERO HIDROFILICO EL CUAL ES UN DERIVADO CELULOSICO, EN PARTICULAR HIDROXIPROPILCELULOSA, HIDROXIPROPILMETILCELULOSA. TAMBIEN SE CARACTERIZA PORQUE SE PRESENTA EN FORMA DE UN COMPRIMIDO FLOTANTE. LA COMPOSICION MEJORA LA BIODISPONIBILIDAD DE LAS BENZAMIDAS POR VIA ORALCHARACTERIZED BECAUSE IT INCLUDES a) AN ACTIVE PRINCIPLE THAT CONSISTS OF A BENZAMIDE OR ITS SALT, PARTICULARLY IS THE CHLORHYDRATE OF TIAPRIDE, AMISULPRIDE, SULPIRIDE, OR ITS SALTS, OR THEIR ENANTIOMERS; b) A CO2 GENERATING SYSTEM, INCLUDING AT LEAST ONE CO2 GENERATING AGENT AND AT LEAST ONE ACID COMPOSITE CHOSEN BETWEEN MONO ACID AND POLYCARBOXYLIC ACIDS; OF PREFERENCE IS THE ACID TARTARICO, SUCCINICO, CITRICO OR ITS SALTS; c) A MEANS THAT ALLOWS THE PARTIAL RETENTION OF CO2 GENERATED BY SUCH A CO2 GENERATING SYSTEM, WHICH CONSISTS OF AT LEAST ONE HYDROPHILIC POLYMER, WHICH IS A CELLULOSIC DERIVATIVE, IN PARTICULAR HYDROXYPROPYLcellulose. IT IS ALSO CHARACTERIZED BECAUSE IT IS PRESENTED IN THE FORM OF A FLOATING TABLET. THE COMPOSITION IMPROVES THE BIOAVAILABILITY OF BENZAMIDES BY ORAL USE
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9704803A FR2762213B1 (en) | 1997-04-18 | 1997-04-18 | PHARMACEUTICAL COMPOSITION WITH GASTRIC RETENTION |
Publications (1)
Publication Number | Publication Date |
---|---|
PE68199A1 true PE68199A1 (en) | 1999-07-15 |
Family
ID=9506077
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE1998000281A PE68199A1 (en) | 1997-04-18 | 1998-04-17 | PHARMACEUTICAL COMPOSITION OF GASTRIC RESIDENCE |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0983065A1 (en) |
JP (1) | JP2001523241A (en) |
KR (1) | KR20010006353A (en) |
CN (1) | CN1252720A (en) |
AR (1) | AR015586A1 (en) |
AU (1) | AU737634B2 (en) |
CA (1) | CA2286081A1 (en) |
FR (1) | FR2762213B1 (en) |
HU (1) | HUP0002455A3 (en) |
IL (1) | IL131995A0 (en) |
JO (1) | JO2017B1 (en) |
MA (1) | MA26482A1 (en) |
NO (1) | NO995039L (en) |
NZ (1) | NZ500288A (en) |
PE (1) | PE68199A1 (en) |
PL (1) | PL336273A1 (en) |
TN (1) | TNSN98049A1 (en) |
WO (1) | WO1998047506A1 (en) |
ZA (1) | ZA983258B (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6169094B1 (en) * | 1998-07-14 | 2001-01-02 | Sanofi-Synthelabo | Compositions of (S) (-)-amisulpride |
FR2784583B1 (en) | 1998-10-16 | 2002-01-25 | Synthelabo | PHARMACEUTICAL COMPOSITION WITH GASTRIC RESIDENCE AND CONTROLLED RELEASE |
FR2790388B1 (en) * | 1999-03-04 | 2001-04-13 | Synthelabo | PHARMACEUTICAL COMPOSITIONS COMPRISING A BENZAMIDE AND AT LEAST ONE ABSORPTION PROMOTER |
EP1245227A1 (en) | 2001-03-31 | 2002-10-02 | Jagotec Ag | A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same |
WO2009157711A2 (en) * | 2008-06-24 | 2009-12-30 | Park Eun-Seok | Gastro-retentive porous tablet and method for preparing same |
FR2949061B1 (en) * | 2009-08-12 | 2013-04-19 | Debregeas Et Associes Pharma | FLOATING MICROGRANULES |
EP2719376B1 (en) * | 2012-10-12 | 2015-03-04 | Omya International AG | Gastroretentive drug formulation and delivery systems and their method of preparation using functionalized calcium carbonate |
BR112020011189A2 (en) | 2017-12-05 | 2020-11-17 | Sunovion Pharmaceuticals Inc. | non-racemic mixtures and uses thereof |
MX2020005517A (en) | 2017-12-05 | 2020-11-09 | Sunovion Pharmaceuticals Inc | Crystal forms and production methods thereof. |
JP7044649B2 (en) * | 2018-06-28 | 2022-03-30 | 株式会社ファンケル | Intragastric floating tablets |
US11160758B2 (en) | 2019-06-04 | 2021-11-02 | Sunovion Pharmaceuticals Inc. | Modified release formulations and uses thereof |
WO2023214018A1 (en) | 2022-05-06 | 2023-11-09 | Galenix Innovations | Gastro-retentive swellable sustained release composition |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2415099A1 (en) * | 1978-01-20 | 1979-08-17 | Ile De France | NEW DERIVATIVES OF 4-AMINO-5-ALKYLSULFONYL ORTHO-ANISAMIDES, THEIR METHODS OF PREPARATION AND THEIR APPLICATION AS PSYCHOTROPES |
FR2554718B1 (en) * | 1983-11-14 | 1986-04-04 | Ethypharm Sa | NEW ORAL SULPIRIDE FORMS FOR SULPIRIDE |
FR2556964A1 (en) * | 1983-12-23 | 1985-06-28 | Ile De France | NEW GALENIC FORMS OF SULPIRIDE USED ORALALLY |
JPS62178518A (en) * | 1986-01-30 | 1987-08-05 | Toho Yakuhin Kogyo Kk | Novel long-acting sulpiride tablet |
JPH0776172B2 (en) * | 1986-04-16 | 1995-08-16 | 藤沢薬品工業株式会社 | Matrice locks |
CA2039742A1 (en) * | 1990-04-23 | 1991-10-24 | Andrew B. Dennis | Tablet composition and method for problem pharmaceutical materials |
-
1997
- 1997-04-18 FR FR9704803A patent/FR2762213B1/en not_active Expired - Fee Related
-
1998
- 1998-04-15 KR KR1019997009438A patent/KR20010006353A/en not_active Application Discontinuation
- 1998-04-15 EP EP98920623A patent/EP0983065A1/en not_active Ceased
- 1998-04-15 IL IL13199598A patent/IL131995A0/en unknown
- 1998-04-15 HU HU0002455A patent/HUP0002455A3/en unknown
- 1998-04-15 CA CA002286081A patent/CA2286081A1/en not_active Abandoned
- 1998-04-15 CN CN98804269A patent/CN1252720A/en active Pending
- 1998-04-15 WO PCT/FR1998/000755 patent/WO1998047506A1/en not_active Application Discontinuation
- 1998-04-15 NZ NZ500288A patent/NZ500288A/en unknown
- 1998-04-15 JP JP54514398A patent/JP2001523241A/en active Pending
- 1998-04-15 AU AU73416/98A patent/AU737634B2/en not_active Ceased
- 1998-04-15 PL PL98336273A patent/PL336273A1/en unknown
- 1998-04-16 TN TNTNSN98049A patent/TNSN98049A1/en unknown
- 1998-04-17 ZA ZA983258A patent/ZA983258B/en unknown
- 1998-04-17 AR ARP980101773A patent/AR015586A1/en unknown
- 1998-04-17 MA MA25037A patent/MA26482A1/en unknown
- 1998-04-17 PE PE1998000281A patent/PE68199A1/en not_active Application Discontinuation
- 1998-04-18 JO JO19982017A patent/JO2017B1/en active
-
1999
- 1999-10-15 NO NO995039A patent/NO995039L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PL336273A1 (en) | 2000-06-19 |
JO2017B1 (en) | 1999-05-15 |
IL131995A0 (en) | 2001-03-19 |
ZA983258B (en) | 1998-10-19 |
HUP0002455A2 (en) | 2000-12-28 |
JP2001523241A (en) | 2001-11-20 |
NZ500288A (en) | 2001-03-30 |
NO995039D0 (en) | 1999-10-15 |
WO1998047506A1 (en) | 1998-10-29 |
EP0983065A1 (en) | 2000-03-08 |
AU737634B2 (en) | 2001-08-23 |
FR2762213B1 (en) | 1999-05-14 |
AU7341698A (en) | 1998-11-13 |
FR2762213A1 (en) | 1998-10-23 |
AR015586A1 (en) | 2001-05-16 |
NO995039L (en) | 1999-12-17 |
CA2286081A1 (en) | 1998-10-29 |
KR20010006353A (en) | 2001-01-26 |
TNSN98049A1 (en) | 2005-03-15 |
CN1252720A (en) | 2000-05-10 |
HUP0002455A3 (en) | 2001-01-29 |
MA26482A1 (en) | 2004-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR199500826A2 (en) | Multiple unit tablet dosage form 2. | |
PE68199A1 (en) | PHARMACEUTICAL COMPOSITION OF GASTRIC RESIDENCE | |
CY1107675T1 (en) | TRAMADOLIS MEDICINES | |
ES2172239T3 (en) | OSMOTIC SYSTEM OF LIBERATION OF PHARMACOS. | |
ES2195344T3 (en) | PHARMACEUTICAL COMPOSITION PRESENTING AN IMPROVED ANTITUMORAL ACTIVITY AND / OR REDUCED SIDE EFFECTS, CONTAINING AN ANTITUMORAL AGENT AND A HYDROXYMIC ACID DERIVATIVE. | |
AR042345A2 (en) | A PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ATEROSCLEROSIS CONTAINING 8.9 - DEHYDROESTERONE OR ITS SALTS OF THE SAME | |
MX9207263A (en) | SYSTEM FOR THE SUPPLY OF AN ACTIVE SUBSTANCE FOR SUSTAINED LIBERATION. | |
DK1390378T3 (en) | Pharmaceutically active uridine esters | |
CY1108823T1 (en) | 2-Hydroxy-3-heteroarylindol derivative as inhibitors of GSK3 | |
PE20050822A1 (en) | FLORPHENICOL DERIVATIVES WITH BETTER SOLUBILITY IN WATER | |
ES2133785T3 (en) | METALOPROTEINASE INHIBITORS. | |
CA2273420A1 (en) | Matrix tablet permitting sustained release of gliclazide after oral administration | |
AR030541A1 (en) | AMYINOPROPYLPHOSPHINIC ACIDS, ITS USE FOR THE MANUFACTURE OF MEDICINES, AND PHARMACEUTICAL FORMULATION | |
RU94045950A (en) | Pharmaceutical preparation and method of its preparing | |
ES2176106B1 (en) | TRIMETAZIDINE PROLONGED MARRIAGE RELEASE COMPRESSED AFTER ORAL ADMINISTRATION. | |
AR056268A1 (en) | TABLETS THAT INCLUDE A BIOLOGICALLY ACTIVE SUBSTANCE AND A EXCIPIENT | |
UY26371A1 (en) | IMIDAZO-3-IL-AMINAS BICICLICAS, PROCEDURE FOR ITS PREPARATION AND MEDICINES THAT CONTAIN THEM | |
IT1314185B1 (en) | PHARMACEUTICAL COMPOSITION FOR ADMINISTRATION OF SUBSTANCES ACTIVELY SOLUBLE IN AQUEOUS MEDIA | |
ES2159362T3 (en) | USE OF 1- (2-NAFT-2-ILETIL) -4- (3-TRIFLUOROMETILFENIL) -1,2,3,6-TETRAHYDROPIRIDINE FOR THE PREPARATION OF MEDICINES INTENDED FOR THE TREATMENT OF AMIOTROPHIC SIDE SCLEROSIS. | |
DK0625355T3 (en) | Tablet with improved bioavailability containing dichloromethylene phosphonic acid as active substance | |
CY1105545T1 (en) | STATIN THERAPY TO ENHANCE THE PRESERVATION OF MENTAL FUNCTION | |
DK72289D0 (en) | CEPHEMCARBOXYLIC ACID ESTERS, THEIR PREPARATION AND USE | |
ES2072647T3 (en) | COMPOSITIONS CONTAINING RANITIDINE / BISMUTE CARBOXYLATE SALTS. | |
BR9608255A (en) | Transdermal therapeutic system (stt) for testosterone administration | |
TR199801082T2 (en) | New phospholipid derivatives of phosphonocarbicylic acids, their production, as well as their use as antiviral pharmaceuticals. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |